For citations:
Krolevets T.S., Livzan M.A. Metabolic-associated fatty liver disease (NAFLD) as a cancer risk factor. Experimental and Clinical Gastroenterology. 2023;(3):120-127. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-211-3-120-127
Krolevets T.S., Livzan M.A. Metabolic-associated fatty liver disease (NAFLD) as a cancer risk factor. Experimental and Clinical Gastroenterology. 2023;(3):120-127. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-211-3-120-127